2nd Quarter - Report
ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION
Firm
Client
Income
—
Expenses
$75,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISA VIDULICH CASAVANT | Policy Director |
| CHARLES HUSSER New | Federal Affairs Manager |
| ANNA HYDE | Vice President, Advocacy and Access |
Health Issues HCR
S.46 - Health Care Affordability Act of 2025 Safe Step Act S.864 - HELP Copays Act CDC Arthritis Program - Appropriations Congressionally Directed Medical Research Program - Appropriations ATPCs Arthritis Research Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISA VIDULICH CASAVANT New | Policy Director |
| CHARLES HUSSER New | Federal Affairs Manager |
| ANNA HYDE | Vice President, Advocacy and Access |
Budget/Appropriations BUD
CDC Arthritis Program - Appropriations Congressionally Directed Medical Research Program - Appropriations H.R.1, the One Big Beautiful Bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISA VIDULICH CASAVANT New | Policy Director |
| CHARLES HUSSER New | Federal Affairs Manager |
| ANNA HYDE | Vice President, Advocacy and Access |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.